A Hospital-Based Pharmacy Intervention Program for Pneumococcal Vaccination

Vondracek, Thomas G.; Pham, Trinh P.; Huycke, Mark M.

doi:10.1001/archinte.158.14.1543

Cited by 43 publications

(27 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study of 102 patients reported an increase in pneumococcal and influenza vaccination rates from 21% and 16% to 67% and 61%, respectively ( P = 0.0001) . Specifically, for pneumococcal vaccine chart reminders, Vondracek et al reported an increase in vaccination rates in 80 patients from 0% to 28.8% and Skledar et al reported an increase in vaccination rates in 1967 patients from 1% to 32.5% . Our study has demonstrated a similar increase in vaccination rates with the involvement of a pharmacist; however, it adds an understanding of the economic advantage of utilizing a pharmacy resident from the hospital perspective.…”

Section: Discussionsupporting

confidence: 55%

A pharmacy resident‐driven pneumococcal vaccination protocol increases vaccination rates in hospitalized patients over 65 years

Wells

Monte

Prescott

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Introduction Pneumococcal disease remains a leading cause of serious illness in adults aged 65 years and older. Despite this, pneumococcal vaccination rates remain suboptimal in this population. Objectives To implement a pharmacy resident‐driven pneumococcal vaccination protocol and to assess vaccination rates and the return on investment (ROI) for patients age 65 years and older admitted to an internal medicine service at an academic medical center. Methods A retrospective, single center review of a newly implemented pharmacy resident‐driven pneumococcal vaccination protocol targeting patients age 65 years and older admitted to an internal medicine service was conducted. The primary outcome was the percentage of eligible patients, as defined by the Center for Disease Control vaccination guidelines, who received a pneumococcal vaccine prior to discharge over a 60‐day period. The secondary outcome was ROI from the hospital perspective, which was calculated as follows: net profit (defined as total revenue—total cost) divided by total cost and then multiplied by 100. Pneumococcal vaccination rates and ROI data were presented descriptively. Results A total of 84 patients were included in the pharmacy resident‐driven protocol, 37 (42%) of whom were up‐to‐date on their pneumococcal vaccinations. Among the remaining 51 vaccine‐eligible patients, 33 (64.7%) were vaccinated prior to hospital discharge: 19/33 (57.6%) received the pneumococcal conjugate vaccine (PCV13) vaccine and 14/33 (42.4%) received the pneumococcal polysaccharide vaccine (PPSV23) vaccine. The total revenue and cost generated by the protocol over the 60‐day period was $8276.10 and $6406.88, respectively. The ROI for the protocol was calculated to be 29.2%. Conclusion The implementation of a pharmacy resident‐driven pneumococcal vaccination protocol increased pneumococcal vaccination rates while also serving as a revenue source. Health care systems may consider implementing a similar protocol to increase vaccination rates and provide novel revenue generating models for their institution.

show abstract

Section: Discussionsupporting

confidence: 55%

A pharmacy resident‐driven pneumococcal vaccination protocol increases vaccination rates in hospitalized patients over 65 years

Wells

Monte

Prescott

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…According to the surveys by the US Centers for Disease Control and Prevention, approximately 20% of persons aged ≥65 years who said they received influenza vaccines reported never having received a pneumococcal vaccination, indicating missed opportunities for pneumococcal vaccine administration at the time of influenza vaccination 10,11. Previously, many in-hospital campaigns have focused on the pneumococcal vaccination of high risk inpatients prior to discharge using computerized reminders, standing order programs, or pre-printed order programs 12,13. Although such strategies might be effective in improving pneumococcal vaccine coverage, a more diverse approach is needed to cover the large population of high risk individuals who are not hospitalized.…”

Section: Discussionmentioning

confidence: 99%

Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors

et al. 2013

View full text Add to dashboard Cite

PurposeDespite the ready availability of pneumococcal vaccine, vaccination rates are quite low in South Korea. This study was designed to assess perceptions and awareness about pneumococcal vaccines among subjects at risk and find strategies to increases vaccine coverage rates.Materials and MethodsA cross sectional, community-based survey was conducted to assess perceptions about the pneumococcal vaccine at a local public health center. In a tertiary hospital, an outpatient-based pneumococcal vaccine campaign was carried out for the elderly and individuals with chronic co-morbidities from May to July of 2007.ResultsBased on the survey, only 7.6% were ever informed about pneumococcal vaccination. The coverage rates of the pneumococcal vaccine before and after the hospital campaign showed an increased annual rate from 3.39% to 5.91%. The most common reason for vaccination was "doctor's advice" (53.3%). As for the reasons for not receiving vaccination, about 75% of high risk patients were not aware of the pneumococcal vaccine, which was the most important barrier to vaccination. Negative clinician's attitude was the second most common cause of non-vaccination.ConclusionAnnual outpatient-based campaigns early in the influenza season may improve pneumococcal vaccine coverage rates. Doctor's advice was the most important encouraging factor for vaccination.

show abstract

“…Because nearly one out of 288 288 288 288 288 three of the patients with invasive pneumococcal disease admitted to Hospital A during 1994 to 1997 had been hospitalized there in the previous 6 months, an inpatient screening and vaccination program could have prevented a substantial number of cases. Hospital-based programs have been shown to be effective in vaccinating highrisk adults in other settings (19)(20)(21), and the use of standing orders to vaccinate eligible adults with pneumococcal vaccine has been recommended by the Task Force on Community Preventive Services (22). Adult vaccination programs in nontraditional settings (e.g., pharmacies, churches, and the workplace) might further raise vaccination coverage in this area (23).…”

Section: Discussionmentioning

confidence: 99%

High Prevalence of Penicillin-Nonsusceptible Streptococcus pneumoniae at a Community Hospital in Oklahoma

Moolenaar

Pasley-Shaw

Harkess

et al. 2000

Emerg. Infect. Dis.

View full text Add to dashboard Cite

A Hospital-Based Pharmacy Intervention Program for Pneumococcal Vaccination

Abstract: A hospital-based pharmacy vaccination program that relied on simple chart reminders was significantly associated with increased vaccination rates among inpatients at risk for invasive pneumococcal disease.

Cited by 43 publications

References 23 publications

A pharmacy resident‐driven pneumococcal vaccination protocol increases vaccination rates in hospitalized patients over 65 years

A pharmacy resident‐driven pneumococcal vaccination protocol increases vaccination rates in hospitalized patients over 65 years

Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors

High Prevalence of Penicillin-Nonsusceptible Streptococcus pneumoniae at a Community Hospital in Oklahoma

Contact Info

Product

Resources

About